Pfizer (PFE) May Seek to Sell Non-Prescription Lipitor
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $27.65 -0.47%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Join SI Premium – FREE
Pfizer (NYSE: PFE) may seek to sell non-prescription, or OTC, Lipitor, according to sources. Shares turned up into the close on the report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer (PFE) PT Raised to $30 at HSBC
- Cullinan Therapeutics to host investor event after Phase 3 lung cancer trial data
- Lyell shifts LYL273 trial timeline, eyes 2027 FDA meeting
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
